EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Saw Palmetto Extract Ameliorates Benign Prostatic Hyperplasia by Regulating 5α‐Reductase and Apoptosis In Vitro and In Vivo

Bo Zhang, Hui Wang, Tianyu Ma, Jiangang Yang

LUTS: Lower Urinary Tract Symptoms · 2025-05 · 17 (3)

DOI: 10.1111/luts.70015 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objectives The therapeutic effect of saw palmetto extract (SPE) in benign prostatic hyperplasia (BPH) has been evaluated in clinical trials. However, the molecular mechanisms of SPE in BPH development are not fully understood. Methods LNCap cell line treated with dihydrotestosterone (DHT) and SD rats induced with testosterone were used, respectively. TUNEL and Muse Cell Analyzer for apoptosis and CCK8 assay for cell viability were performed to investigate the effects of SPE against BPH. Histological changes were examined by HE staining. Protein expression was analyzed for AR, PSA, SRC‐1, and 5AR2 by Western blot, and the levels of DHT and testosterone in rat serum were quantified by ELISA. Results SPE treatment could accelerate the apoptosis of cells and decrease the expressions of TNF‐α, IL‐1β and IL‐18. TUNEL staining revealed an increase in positive staining after SPE treatment. Rats treated with SPE exhibited a reduction in prostate weight. SPE treatment led to a decrease in serum DHT and testosterone levels. SPE treatment significantly reduced the protein levels of AR, PSA, SRC‐1, and 5AR2 in vitro and in vivo. Conclusions SPE possesses anti‐proliferative and pro‐apoptotic effects by inhibiting 5α‐reductase and DHT expression in vitro and in vivo, thereby mitigating the progression of BPH.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →